Abacus FCF Advisors LLC increased its position in Colgate-Palmolive by 11.0% during the third quarter, acquiring an additional 22,105 shares to bring its total holding to 223,175 shares. This position represents approximately 2.4% of the firm’s portfolio and ranks as its 12th largest, with a reported value of $17.84 million as of the latest SEC filing. Other notable institutional moves include Baron Wealth Management adding 414 shares (7.7% increase), Diversified Trust Co. purchasing 10,892 shares (12.8% increase), and Mirova US LLC boosting its stake by 50.9% with an extra 9,614 shares. Overall, hedge funds and institutional investors account for 80.41% of the company’s outstanding shares.

During the past quarter, research firms have revised their outlooks on Colgate-Palmolive. Deutsche Bank maintained an overweight stance, while Morgan Stanley cut its target by roughly 9.4% and reaffirmed an overweight rating. Barclays trimmed its objective by about 2.4% and held an equal weight rating, whereas JPMorgan increased its outlook modestly and kept an overweight recommendation. Bank of America reduced its target number and maintained a buy rating. In total, ten analysts currently issue buy recommendations, five are neutral, and one is negative, resulting in an average consensus of Moderate Buy.

Colgate-Palmolive reported third-quarter adjusted earnings per share of $0.91, $0.02 above consensus estimates, and revenue of $5.13 billion, slightly below forecasts. The company achieved year-over-year sales growth of 1.9%, a net margin of 14.47%, and an exceptionally high return on equity of 333.39%. Management reaffirmed full-year guidance, with analysts projecting annual earnings of approximately $3.75 per share based on current trends in oral care, personal care, home care, and pet nutrition segments.

The board approved a quarterly cash dividend of $0.52 per share, payable on February 13 to shareholders of record as of January 21, with an ex-dividend date of January 21. This distribution equates to an annualized payout of $2.08 per share and a yield of 2.6%, reflecting a dividend payout ratio of 58.26% and underlining the company’s commitment to returning capital to investors.